Accessibility Menu
 
Exact Sciences logo

Exact Sciences

(NASDAQ) EXAS

Current Price$104.93
Market Cap$20.03B
Since IPO (2001)+611%
5 Year-22%
1 Year+137%
1 Month+2%

Exact Sciences Financials at a Glance

Market Cap

$20.03B

Revenue (TTM)

$3.25B

Net Income (TTM)

$207.95M

EPS (TTM)

$-1.10

P/E Ratio

-94.98

Dividend

$0.00

Beta (Volatility)

1.25 (Average)

Price

$104.93

Volume

946,113

Open

$104.94

Previous Close

$104.93

Daily Range

$104.90 - $104.98

52-Week Range

$38.81 - $104.98

EXAS: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Exact Sciences

Industry

Biotechnology

Employees

7,200

CEO

Kevin T. Conroy

Headquarters

Madison, WI 53719, US

EXAS Financials

Key Financial Metrics (TTM)

Gross Margin

70%

Operating Margin

-6%

Net Income Margin

-6%

Return on Equity

-9%

Return on Capital

-4%

Return on Assets

-4%

Earnings Yield

-1.05%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$20.03B

Shares Outstanding

190.89M

Volume

946.11K

Short Interest

0.00%

Avg. Volume

2.55M

Financials (TTM)

Gross Profit

$2.26B

Operating Income

$99.08M

EBITDA

$122.50M

Operating Cash Flow

$491.44M

Capital Expenditure

$134.66M

Free Cash Flow

$356.78M

Cash & ST Invst.

$964.71M

Total Debt

$2.52B

Exact Sciences Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$878.38M

+23.1%

Gross Profit

$615.83M

+43.5%

Gross Margin

70.11%

N/A

Market Cap

$20.03B

N/A

Market Cap/Employee

$2.90M

N/A

Employees

6,900

N/A

Net Income

$85.95M

+90.1%

EBITDA

$20.33M

+97.5%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$1.56B

+9.2%

Accounts Receivable

$298.65M

+20.0%

Inventory

$166.20M

+2.4%

Long Term Debt

$2.50B

+0.7%

Short Term Debt

$39.29M

-85.8%

Return on Assets

-3.55%

N/A

Return on Invested Capital

-3.84%

N/A

Free Cash Flow

$120.45M

+1020.7%

Operating Cash Flow

$151.69M

+222.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ROIVRoivant Sciences Ltd.
$27.70-0.36%
RVMDRevolution Medicines, Inc.
$95.78-3.54%
VTRSViatris Inc.
$13.20-2.22%
BBIOBridgeBio Pharma, Inc.
$68.54-2.18%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$43.87-0.05%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.08-0.06%
RITMRithm Capital
$8.77-0.03%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.82+0.06%

Questions About EXAS

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.